Resuscitative TEE Collaborative Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania

About this trial

The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE.

The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings.

The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.

Eligibility criteria

Qualifiers

Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.

Disqualifiers

Children (age under 18 years)

Vulnerable populations

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 5 trial groups

Sponsors and collaborators

University of Pennsylvania

Lead sponsor

Weill Medical College of Cornell University

Sponsor institution

Weill Medical College of Cornell University

Collaborator